Interestingly, the pro-apoptotic protein BIM (Fig. 2d), showed some increase with romidepsin in DLBCL cell lines (Toledo and Ly03), which was in agreement with the PARP1 cleavage pattern detected with romidepsin treatment. The gene discussed is BCL2L11; the disease is diffuse large B-cell lymphoma.